GLASSIA is a medicine containing human Alpha-Proteinase Inhibitor (Alpha1-PI) that is used to treat adults with lung disease (emphysema) because of severe Alpha1-antitrypsin deficiency. GLASSIA is not meant to be used as a therapy for lung disease other than severe Alpha deficiency. Effects of GLASSIA on worsening lung function and emphysema progression have not been proven in clinical trials. Long-term effects of Alpha1 replacement and maintenance therapy have not been studied.
For more information, visit the patient website for this drug. Speak with your healthcare provider to learn if this drug is right for you.